Ensaio em fase de recrutamento = ; Ensaio a decorrer = ; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

ITALIA

EMILIA ROMAGNA
FERRARA

A Phase III, randomized, double blind, placebo-controlled clinical study to assess the efficacy and safety of GSK2402968 in subjects with Duchenne muscular dystrophy - IT

A.O.U. Sant'Anna - Polo Chimico-Bio-Medico

U.O.C. di Genetica Medica

Mais detalhes

ITALIA

EMILIA ROMAGNA
FERRARA

An open-label extension study of the long-term safety, tolerability and efficacy of GSK2402968 in subjects with Duchenne Muscular Dystrophy - IT

A.O.U. Sant'Anna - Polo Chimico-Bio-Medico

U.O.C. di Genetica Medica

Mais detalhes

ITALIA

EMILIA ROMAGNA
FERRARA

A phase I/IIa, open label, escalating dose, pilot study to assess the effect, safety, tolerability and pharmacokinetics of multiple subcutaneous doses of PRO044 in patients with Duchenne muscular dystrophy - IT

A.O.U. Sant'Anna - Polo Chimico-Bio-Medico

U.O.C. di Genetica Medica

Mais detalhes

ITALIA

EMILIA ROMAGNA
FERRARA

A Phase II, Open Label, Extension Study to Assess the Effect of PRO044 in Patients With Duchenne Muscular Dystrophy - IT

A.O.U. Sant'Anna - Polo Chimico-Bio-Medico

U.O.C. di Genetica Medica

Mais detalhes

ITALIA

EMILIA ROMAGNA
FERRARA

A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy - IT

A.O.U. Sant'Anna - Polo Chimico-Bio-Medico

U.O.C. di Genetica Medica

Mais detalhes